These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8524106)

  • 21. Malignant transformation of a mouse liver epithelial cell line by transfection of an activated c-H-ras gene with a point mutation at codon 12.
    Kanda H; Lee GH; Nomura K; Ohtake K; Kitagawa T
    Carcinogenesis; 1993 May; 14(5):1061-3. PubMed ID: 8504467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene ecology: a cis-acting gene-to-gene interaction due to the spatial arrangement of genes in chromosomes affects neighbouring transfected c-H-ras expression.
    Naora H; Xu ZZ; Miyahara K; Liszczynsky H; Seno S
    Chromosome Res; 1994 May; 2(3):171-83. PubMed ID: 8069461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmid rescue of an oncogenic sequence containing a mouse mammary tumor virus gene.
    Van Klaveren P; Haaksma T; Dijk H; Bentvelzen P
    Anticancer Res; 1994; 14(2A):597-601. PubMed ID: 7517122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice.
    Fernandes G; Chandrasekar B; Troyer DA; Venkatraman JT; Good RA
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6494-8. PubMed ID: 7604020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinia virus expression of p21 rasAsn-17.
    de Vries-Smits AM; Burgering BM; Bos JL
    Methods Enzymol; 1995; 255():221-9. PubMed ID: 8524105
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1.
    Davies BR; Davies MP; Gibbs FE; Barraclough R; Rudland PS
    Oncogene; 1993 Apr; 8(4):999-1008. PubMed ID: 8455951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.
    D'Cruz CM; Gunther EJ; Boxer RB; Hartman JL; Sintasath L; Moody SE; Cox JD; Ha SI; Belka GK; Golant A; Cardiff RD; Chodosh LA
    Nat Med; 2001 Feb; 7(2):235-9. PubMed ID: 11175856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction with the nuclear matrix of a chimeric construct containing a replication origin and a transcription unit.
    Adom JN; Gouilleux F; Richard-Foy H
    Biochim Biophys Acta; 1992 Dec; 1171(2):187-97. PubMed ID: 1336395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport.
    Gnudi L; Frevert EU; Houseknecht KL; Erhardt P; Kahn BB
    Mol Endocrinol; 1997 Jan; 11(1):67-76. PubMed ID: 8994189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-localization of ras gene products and cathepsin L in cytoplasmic vesicles in v-Ha-ras-transformed NIH3T3 mouse fibroblasts.
    Hiwasa T; Sawada T; Tanaka K; Chiba T; Tanaka T; Kominami E; Katunuma N; Sakiyama S
    Biomed Biochim Acta; 1991; 50(4-6):579-85. PubMed ID: 1801726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
    Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
    Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of ras p21 correlates with increased rate of abnormal mitosis in NIH3T3 cells.
    Hagag N; Diamond L; Palermo R; Lyubsky S
    Oncogene; 1990 Oct; 5(10):1481-9. PubMed ID: 2174524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CArG binding factor A (CBF-A) is involved in transcriptional regulation of the rat Ha-ras promoter.
    Mikheev AM; Mikheev SA; Zhang Y; Aebersold R; Zarbl H
    Nucleic Acids Res; 2000 Oct; 28(19):3762-70. PubMed ID: 11000268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
    Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
    Cancer Gene Ther; 2000 Sep; 7(9):1231-40. PubMed ID: 11023195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyomavirus middle-sized tumor antigen modulates c-Jun phosphorylation and transcriptional activity.
    Srinivas S; Schönthal A; Eckhart W
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10064-8. PubMed ID: 7937838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.